To evaluate the contribution of these pathways in APC/KRAS-mutant CRC, we utilized 1CT isogenic cells expressing shAPC (1CT-A), mutant KRASG12V (1CT-K), or both (1CT-AK)12. This evidence concerns the gene APC and colorectal carcinoma.